CL2007003136A1 - Composicion farmaceutica analgesica que comprende una combinacion de carisoprodol, sus enantiomeros o sus sales cristalinas y clonixinato de lisina o sus hidratos o sus sales, en una proporcion carisoprodol:clonixinato de lisina desde 1:0,5 hasta 1:1 - Google Patents

Composicion farmaceutica analgesica que comprende una combinacion de carisoprodol, sus enantiomeros o sus sales cristalinas y clonixinato de lisina o sus hidratos o sus sales, en una proporcion carisoprodol:clonixinato de lisina desde 1:0,5 hasta 1:1

Info

Publication number
CL2007003136A1
CL2007003136A1 CL200703136A CL2007003136A CL2007003136A1 CL 2007003136 A1 CL2007003136 A1 CL 2007003136A1 CL 200703136 A CL200703136 A CL 200703136A CL 2007003136 A CL2007003136 A CL 2007003136A CL 2007003136 A1 CL2007003136 A1 CL 2007003136A1
Authority
CL
Chile
Prior art keywords
lisine
clonixinate
carisoprodol
salts
hydrats
Prior art date
Application number
CL200703136A
Other languages
English (en)
Inventor
De Los Angeles Aguile Graciela
Original Assignee
Farmaceuticos Rayere S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaceuticos Rayere S A filed Critical Farmaceuticos Rayere S A
Publication of CL2007003136A1 publication Critical patent/CL2007003136A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CL200703136A 2006-10-30 2007-10-30 Composicion farmaceutica analgesica que comprende una combinacion de carisoprodol, sus enantiomeros o sus sales cristalinas y clonixinato de lisina o sus hidratos o sus sales, en una proporcion carisoprodol:clonixinato de lisina desde 1:0,5 hasta 1:1 CL2007003136A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/MX2006/000118 WO2008054188A1 (es) 2006-10-30 2006-10-30 Composición farmacéutica sinergística de carisoprodol y clonixinato de lisina

Publications (1)

Publication Number Publication Date
CL2007003136A1 true CL2007003136A1 (es) 2008-02-15

Family

ID=39344480

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703136A CL2007003136A1 (es) 2006-10-30 2007-10-30 Composicion farmaceutica analgesica que comprende una combinacion de carisoprodol, sus enantiomeros o sus sales cristalinas y clonixinato de lisina o sus hidratos o sus sales, en una proporcion carisoprodol:clonixinato de lisina desde 1:0,5 hasta 1:1

Country Status (4)

Country Link
AR (1) AR060205A1 (es)
CL (1) CL2007003136A1 (es)
MX (1) MX2007012517A (es)
WO (1) WO2008054188A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1103205A2 (pt) * 2011-06-03 2014-02-25 Eurofarma Lab Ltda Composição farmacêutica oral e uso da composição farmacêutica oral

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582513B2 (en) * 1984-12-26 1989-03-23 Eugene M. Laska Method for using musculoskeletal relaxants
US5260337A (en) * 1992-07-29 1993-11-09 Merck & Co., Inc. Ibuprofen-muscle relaxant combinations
WO1997020551A1 (en) * 1995-12-05 1997-06-12 Adcock Ingram Limited Pharmaceutical composition comprising a skeletal muscle relaxant, a non-steroidal antiinflammatory agent and an analgesic

Also Published As

Publication number Publication date
MX2007012517A (es) 2009-02-26
AR060205A1 (es) 2008-06-04
WO2008054188A1 (es) 2008-05-08

Similar Documents

Publication Publication Date Title
CY2020013I2 (el) Φαρμακευτικη συνθεση που περιεχει γλυκοπυρρολικο και εναν αγωνιστη βητα2 αδρενοϋποδοχεα
DK3421471T3 (da) Purin- og deazapurinderivater som farmaceutiske forbindelser
DE602007002909D1 (de) Geschoss zur verabreichung eines medikaments
CR10505A (es) Aminopirazolopiridinas sustituidas y sus sales, sus preparaciones y composiciones farmaceuticas que las comprenden
ATE501135T1 (de) Piperidinamino-benzimidazol-derivate al respiratorisches syncytialvirus replikation inhibitoren
NO20084526L (no) Tienpyrimidiner med MNKL/MNK2 inhiberende aktivitet for farmasøytiske sammensetninger
BRPI0810928A2 (pt) "composição farmacêutica"
BRPI0716365A2 (pt) "artigo odontolàgico"
DK2277509T3 (da) DPP IV inhibitorformuleringer
ES2401205T8 (es) Composiciones orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo
HK1137762A1 (en) 1, 4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
ATE489953T1 (de) Manipulationssichere orale pharmazeutische dosierformen enthaltend ein opiatanalgetikum
BRPI0715712A2 (pt) Composição farmacêutica
ATE517619T1 (de) Stabilisierte pharmazeutische zusammensetzung mit fesoterodin
BRPI0719393A2 (pt) Composição farmacêutica
BRPI0716445A2 (pt) composiÇço farmacÊutica
BRPI0720234A2 (pt) Composição farmacêutica
EP2039689A4 (en) PROCESS FOR PREPARING OPTICALLY ACTIVE 3-AMINO-2-HYDROXYPROPIONIC ACID CYCLOPROPYLAMID DERIVATIVES AND SALTS THEREOF
BRPI0811476A2 (pt) Dosagem intravenosa e oral de um inibidor de p2y12 de ação direta e reversível
DK200900115U1 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
EP2062579A4 (en) SOLID PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION COMPRISING OPTICALLY STABLE RAMOSETRON
DK2049480T3 (da) 2-arylindolderivater som mPGES-1-hæmmere
BRPI0720684A2 (pt) composto, medicamento, composição farmacêutica que contém e uso do composto
ITFI20080016A1 (it) Formulazioni farmaceutiche orali contenenti gliclazide.
CL2007003136A1 (es) Composicion farmaceutica analgesica que comprende una combinacion de carisoprodol, sus enantiomeros o sus sales cristalinas y clonixinato de lisina o sus hidratos o sus sales, en una proporcion carisoprodol:clonixinato de lisina desde 1:0,5 hasta 1:1